A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DEN / dengue virus

[Related PubMed/MEDLINE]
Total Number of Papers: 58
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DEN  (>> Co-occurring Abbreviation)
Long Form:   dengue virus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for Diagnostics. CCHFV, CHIKV, EBOV, ELISA, LASV, MARV, ONNV, PRNT, RVFV, WNV, YFV
2019 Dengue virus is an under-recognised causative agent of acute encephalitis syndrome (AES): Results from a four year AES surveillance study of Japanese encephalitis in selected states of India. AES, CSF, JEV
2014 Computational prediction and experimental characterization of a "size switch type repacking" during the evolution of dengue envelope protein domain III (ED3). ---
2014 Surfactant-modified nanoclay exhibits an antiviral activity with high potency and broad spectrum. JEV, NSP
2013 MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. JEV, MCPIP1
2012 Dengue virus targets the adaptor protein MITA to subvert host innate immunity. IRF3
2012 Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein. TNF
2010 Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. ---
2010 Flow cytometric analysis of dengue virus-infected cells in peripheral blood. DEN3, mAb, mAbs, PE
10  2010 Persistent, triple-virus co-infections in mosquito cells. JE
11  2010 The interferon stimulator mitochondrial antiviral signaling protein facilitates cell death by disrupting the mitochondrial membrane potential and by activating caspases. dsRNA, IFN
12  2010 Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon. 3'-UTR, miR-122, miRNAs, MRE
13  2009 Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection. OAS, OASL
14  2009 Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. ---
15  2008 An alternative method for the synthesis of competitor RNA transcripts useful for specific detection and quantitation of dengue virus serotype 2 genome and replicative intermediate RNA. RT-PCR
16  2008 Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. NS3, PBMCs
17  2008 [Effects of RNA elements within 3'untranslated region on dengue virus translation]. Luc, VIRG
18  2007 Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens. DEN-1, mAbs
19  2007 Mosquito La protein binds to the 3' untranslated region of the positive and negative polarity dengue virus RNAs and relocates to the cytoplasm of infected cells. UTRs
20  2006 Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. HS, PPS
21  2006 Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. UTR
22  2006 Inhibition of dengue virus replication by mycophenolic acid and ribavirin. MPA, RBV
23  2006 Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. PPMOs
24  2006 Murine model for dengue virus-induced lethal disease with increased vascular permeability. DHF/DSS, TNF-alpha
25  2006 Secondary structure of dengue virus type 4 3' untranslated region: impact of deletion and substitution mutations. UTR
26  2006 Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. GAG
27  2005 Control of translation by the 5'- and 3'-terminal regions of the dengue virus genome. CS, UTRs
28  2005 Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. ---
29  2005 Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. DEN2, LLnL
30  2005 Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. ---
31  2005 Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. CPEs, DEN-2, JEV, PARP, PI3K
32  2005 S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells. DEN2, THY
33  2005 The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. ---
34  2004 Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. AAV, DCs, siRNA
35  2004 Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. CNS, DEN2, NK, p.i, WBC
36  2004 Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. CNS
37  2004 Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining. PBMC
38  2004 [Demonstration of simultaneous infection with dengue type 2 and 3 in a Chinese patient]. ---
39  2003 Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. DBI, NS-1, RT-PCR
40  2003 Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. IgM
41  2002 HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. DF, DHF
42  2002 Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. ELISA, IgM, JEV
43  2002 Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. ---
44  2002 Phylogenetic evidence for adaptive evolution of dengue viruses in nature. ---
45  2001 Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. DF, DHF
46  2001 De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. RdRp, TRs
47  2001 Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. DF, DHF, DSS, IgM
48  2000 Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. ---
49  2000 Failure of dengue-2 virus antibody to interfere with the isolation of dengue-2 virus from Aedes aegypti (Diptera: Culicidae). ---
50  2000 Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. HCV, HS
51  2000 Molecular epidemiology of dengue viruses in Brazil. ---
52  2000 Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. JEV, PV
53  1999 Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. NS1, YF
54  1999 Seroprevalence of dengue, chikungunya and Sindbis virus infections in German aid workers. CHIK
55  1998 Study of Dengue virus infection in SCID mice engrafted with human K562 cells. SCID
56  1995 Imported dengue virus infections in German tourists. IIFA
57  1994 Hepatitis C and arboviral antibodies in the island populations of Mauritius and Rodrigues. HCV, SIN, STD, WN
58  1986 Partial sequence analysis of cloned dengue virus type 2 genome. nt